Consistent with these results, our study indicated that 1,25(OH)2D3 deletion negatively regulated the mTOR2/AKT pathway by directly inhibiting the transcription of Sirt1 and subsequent Rictor, thereby enhancing hepatic glucose production and causing hyperglycaemia as well as glucose metabolism dysfunction. The gene discussed is AKT1; the disease is Hyperglycemia.